Moises Zuniga v. HHS - Influenza, Guillain-Barre syndrome (GBS) (2024)
Case summary [AI summaries can sometimes make mistakes]
On September 21, 2022, Moises Zuniga filed a petition alleging that an influenza vaccination administered on September 24, 2019 caused Guillain-Barre syndrome. Respondent conceded entitlement in a Rule 4(c) report filed September 5, 2023, and Special Master Nora Beth Dorsey found Mr.
Zuniga entitled to compensation that same day. The public entitlement ruling and damages proffer do not describe his onset, hospitalization, neurologic testing, treatment, residual symptoms, or expert evidence.
On December 3, 2024, the Special Master awarded damages based on respondent's proffer. Mr.
Zuniga received $621,946.34 as a lump sum: $250,000.00 for pain and suffering, $30,608.88 for past unreimbursable expenses, and $341,337.46 for past lost wages. A later November 20, 2025 decision addressed attorneys' fees and costs only.
Theory of causation
Adult petitioner; influenza vaccine September 24, 2019; Table GBS. COMPENSATED. Respondent conceded entitlement September 5, 2023; damages awarded December 3, 2024. Award $621,946.34 = $250,000.00 pain/suffering + $30,608.88 expenses + $341,337.46 past lost wages. Public text lacks clinical chronology. SM Dorsey. Petition filed September 21, 2022.
Source PDFs
USCOURTS-cofc-1_22-vv-01345